Literature DB >> 19235169

Serum protein profiling by solid phase extraction and mass spectrometry: a future diagnostics tool?

Anne K Callesen1, Jonna S Madsen, Werner Vach, Torben A Kruse, Ole Mogensen, Ole N Jensen.   

Abstract

Serum protein profiling by MS is a promising method for early detection of disease. Important characteristics for serum protein profiling are preanalytical factors, analytical reproducibility and high throughput. Problems related to preanalytical factors can be overcome by using standardized and rigorous sample collection and sample handling protocols. The sensitivity of the MS analysis relies on the quality of the sample; consequently, the blood sample preparation step is crucial to obtain pure and concentrated samples and enrichment of the proteins and peptides of interest. This review focuses on the serum sample preparation step prior to protein profiling by MALDI MS analysis, with particular focus on various SPE methods. The application of SPE techniques with different chromatographic properties such as RP, ion exchange, or affinity binding to isolate specific subsets of molecules (subproteomes) is advantageous for increasing resolution and sensitivity in the subsequent MS analysis. In addition, several of the SPE sample preparation methods are simple and scalable and have proven easy to automate for higher reproducibility and throughput, which is important in a clinical proteomics setting.

Mesh:

Substances:

Year:  2009        PMID: 19235169     DOI: 10.1002/pmic.200800382

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  19 in total

1.  Quality control based on isotopic distributions for high-throughput MALDI-TOF and MALDI-FTICR serum peptide profiling.

Authors:  Simone Nicolardi; Magnus Palmblad; Hans Dalebout; Marco Bladergroen; Rob A E M Tollenaar; André M Deelder; Yuri E M van der Burgt
Journal:  J Am Soc Mass Spectrom       Date:  2010-05-12       Impact factor: 3.109

Review 2.  Opportunities and challenges facing biomarker development for personalized head and neck cancer treatment.

Authors:  Alexandra Lucs; Benjamin Saltman; Christine H Chung; Bettie M Steinberg; David L Schwartz
Journal:  Head Neck       Date:  2012-01-27       Impact factor: 3.147

3.  Automatic selection of preprocessing methods for improving predictions on mass spectrometry protein profiles.

Authors:  Richard C Pelikan; Milos Hauskrecht
Journal:  AMIA Annu Symp Proc       Date:  2010-11-13

4.  Serum peptide expression and treatment responses in patients with advanced non-small-cell lung cancer.

Authors:  Juan An; Chuan-Hao Tang; Na Wang; Yi Liu; Jin Lv; Bin Xu; Xiao-Yan Li; Wan-Feng Guo; Hong-Jun Gao; Kun He; Xiao-Qing Liu
Journal:  Oncol Lett       Date:  2018-04-11       Impact factor: 2.967

Review 5.  Mass-spectrometry-based clinical proteomics--a review and prospective.

Authors:  Carol E Parker; Terry W Pearson; N Leigh Anderson; Christoph H Borchers
Journal:  Analyst       Date:  2010-06-02       Impact factor: 4.616

6.  Enhancement in MALDI-TOF MS analysis of the low molecular weight human serum proteome.

Authors:  Christine L Gatlin; Krista Y White; Maureen B Tracy; Christopher E Wilkins; O John Semmes; Julius O Nyalwidhe; Richard R Drake; Dariya I Malyarenko
Journal:  J Mass Spectrom       Date:  2011-01       Impact factor: 1.982

7.  The Use of Principal Component Analysis in MALDI-TOF MS: a Powerful Tool for Establishing a Mini-optimized Proteomic Profile.

Authors:  Changli Shao; Yaping Tian; Zhennan Dong; Jing Gao; Yanhong Gao; Xingwang Jia; Guanghong Guo; Xinyu Wen; Chaoguang Jiang; Xueji Zhang
Journal:  Am J Biomed Sci       Date:  2012

8.  HDL in humans with cardiovascular disease exhibits a proteomic signature.

Authors:  Tomás Vaisar; Philip Mayer; Erik Nilsson; Xue-Qiao Zhao; Robert Knopp; Bryan J Prazen
Journal:  Clin Chim Acta       Date:  2010-03-20       Impact factor: 3.786

9.  Rapid development of sensitive, high-throughput, quantitative and highly selective mass spectrometric targeted immunoassays for clinically important proteins in human plasma and serum.

Authors:  Bryan Krastins; Amol Prakash; David A Sarracino; Dobrin Nedelkov; Eric E Niederkofler; Urban A Kiernan; Randall Nelson; Maryann S Vogelsang; Gouri Vadali; Alejandra Garces; Jennifer N Sutton; Scott Peterman; Gregory Byram; Bruno Darbouret; Joëlle R Pérusse; Nabil G Seidah; Benoit Coulombe; Johan Gobom; Erik Portelius; Josef Pannee; Kaj Blennow; Vathany Kulasingam; Lewis Couchman; Caje Moniz; Mary F Lopez
Journal:  Clin Biochem       Date:  2013-01-08       Impact factor: 3.281

10.  Evaluation and optimization of mass spectrometric settings during data-dependent acquisition mode: focus on LTQ-Orbitrap mass analyzers.

Authors:  Anastasia Kalli; Geoffrey T Smith; Michael J Sweredoski; Sonja Hess
Journal:  J Proteome Res       Date:  2013-05-31       Impact factor: 4.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.